Atrazine
Also known as: 2-chloro-4-(ethylamino)-6-(isopropylamino)-s-triazine · AAtrex · Gesaprim
Overview
Atrazine is the second most widely used herbicide in the United States and one of the most common chemical contaminants of groundwater and surface water in the country. It is applied primarily to corn, sorghum, and sugarcane crops, and its persistence in the environment means that millions of Americans are exposed through drinking water year-round — often at concentrations exceeding EPA safety thresholds. Atrazine was banned in the European Union in 2004 due to persistent groundwater contamination, yet remains in widespread use in the US.
Atrazine is one of the most comprehensively studied endocrine disruptors in the scientific literature. Its primary mechanism of endocrine disruption is the upregulation of the enzyme aromatase (CYP19A1) — the enzyme responsible for converting androgens (testosterone) into estrogens (estradiol). By artificially elevating aromatase activity, atrazine effectively feminizes exposed organisms by shifting the androgen-to-estrogen ratio toward estrogen dominance. This effect has been documented across species from amphibians to mammals, and the evidence for human impact is substantial and growing.
The landmark studies by Dr. Tyrone Hayes at UC Berkeley demonstrated that atrazine exposure at concentrations as low as 0.1 parts per billion (ppb) — below the EPA's 3 ppb drinking water standard — caused male frogs to develop female reproductive organs (hermaphroditism) and in some cases to completely change sex, becoming reproductively functional females. These findings have been replicated across multiple species and represent a profound demonstration of atrazine's endocrine-disrupting potency.
Primary Sources
Drinking water (tap water in agricultural regions, particularly the US Corn Belt states: Iowa, Illinois, Indiana, Ohio, Kansas, Nebraska); surface water runoff from corn and sorghum fields; food residues on treated crops; occupational exposure in agriculture.
Health Effects
DEVELOPING MALE FETUS & INFANT:
Atrazine exposure during critical windows of male sexual differentiation suppresses testosterone production and upregulates aromatase, disrupting the masculinization of the developing brain and reproductive tract. This is associated with cryptorchidism (undescended testes), hypospadias (urethral malformation), reduced anogenital distance (a marker of feminization), and impaired testicular development. These effects can be permanent and irreversible, as they occur during developmental windows that do not reopen.
DEVELOPING FEMALE FETUS & INFANT:
In females, atrazine's estrogenic effects can accelerate breast tissue development and alter the timing of puberty. Prenatal exposure has been associated with altered mammary gland development and increased susceptibility to mammary tumors in animal models. Disruption of the hypothalamic-pituitary-gonadal (HPG) axis during development can alter the programming of the female reproductive system.
ADULT MALES:
In adult men, atrazine exposure suppresses testosterone synthesis through aromatase upregulation, contributing to hypogonadism, reduced libido, erectile dysfunction, and infertility. Studies have documented reduced sperm count, motility, and morphology in men with higher atrazine exposure. The feminizing effect manifests as gynecomastia (breast tissue development in men), reduced muscle mass, increased body fat, fatigue, and depression — a clinical picture consistent with low testosterone and estrogen dominance. Atrazine is also classified as a possible human carcinogen (IARC Group 2B) with associations to non-Hodgkin's lymphoma and ovarian cancer.
ADULT FEMALES:
In adult women, atrazine's estrogenic activity contributes to estrogen dominance, which is associated with uterine fibroids, endometriosis, polycystic ovary syndrome (PCOS), and estrogen-receptor-positive breast cancer. Disruption of the luteinizing hormone (LH) surge — which triggers ovulation — can cause anovulatory cycles and infertility. Atrazine has also been associated with delayed puberty in some female populations and with adverse pregnancy outcomes including low birth weight and preterm birth.
IMMUNE EFFECTS (ALL POPULATIONS):
Atrazine suppresses both innate and adaptive immune function, reducing NK cell activity, T-cell proliferation, and antibody production. PBMC testing is particularly informative for atrazine because it captures both the intracellular chemical burden and — via EIS — the resulting functional immune cell damage.
Detection Method
This toxin is detected and quantified using HRMS (LC or GC) analysis of isolated PBMCs. The intracellular accumulation of this compound in lymphocytes and monocytes provides a more accurate reflection of chronic systemic burden than conventional serum or urine testing.